The Legal 500

Twitter Logo Youtube Circle Icon LinkedIn Icon

DMD Advocates

121, MAKER CHAMBER IV, NARIMAN POINT, MUMBAI 400 021, INDIA
Tel:
Work +91 22 4356 5555
Email:
Web:
www.dmdadvocates.com
Mumbai, New Delhi

The firm

DMD Advocates is a leading full-service law firm in India with focus on solutions and results through a unique holistic approach that blends its expertise and decades of experience in four core practice areas – litigation and dispute resolution (litigation), corporate, taxation and intellectual property rights (IPR).

The firm is result of a merger between two established law firms: Dutt & Menon in New Delhi, founded by Ms Anuradha Dutt and Ms Vijayalakshmi Menon and Dunmorr Sett in Mumbai, founded by Ms Fereshte D Sethna. It was set up with the vision to provide comprehensive, measurable and high-quality solutions with best service experience.

With over three decades of extensive multi-sectoral and multi-jurisdictional experience, the firm provides a wide range of legal, regulatory and advisory services to a global clientele, including leading Indian and multinational companies, business groups, banks and financial institutions, public sector undertakings, and some of the most sought after Fortune 100 and Fortune 500 companies.

The unique client-focused approach, coupled with a high degree of responsiveness, keeps the firm at the forefront and involved in the country’s headline litigation, arbitration and transactions. An experienced team structure and a pool of more than 65 multi-specialists allow the firm to deliver quality solutions with maximum partner attention and expert advice.

The firm believes in constructive partnership and collaboration, and works as an extension of clients’ in-house legal teams, leveraging its expertise to deliver high-quality legal and business advice. The firm is often called upon to ascertain legal risks, devise legal strategies, structure solutions and resolve conflicts for high-stake matters.

The firm has working relationships with global firms and has been involved in significant international arbitration and transactions, particularly for US-based companies. Internationally, DMD handles cases at the International Chamber of Commerce, the London Court of International Arbitration and the London Maritime Arbitrators’ Association.

Additionally, DMD has vast experience in cross-border transactions. DMD has been engaged in launching investment funds internationally, assisting in structuring and closing investments by private equity and venture capital firms in India, assisting with cross-border mergers and acquisitions, helping with corporate restructuring involving global assets, and advising on international project financing and capital markets transactions.

Areas of practice

Litigation and dispute resolution: litigation in courts, forums and tribunals; domestic and international arbitration; BITs and international treaty arbitration; corporate and commercial litigation; competition; and industrial and employment litigation

International litigation and alternate dispute resolution: cross-border, multi-sectoral litigation; international arbitration, conciliation and mediation; international corporate white-collar crime; forensic investigations; and maritime-based litigation

Corporate and commercial: M&A – domestic and cross-border; capital markets (including IPOs); investment funds (private equity, venture capital and hedge funds); corporate finance; project finance; structured finance (including asset reconstruction companies); banking and NBFCs; joint ventures and foreign investments; corporate re-organisations and restructuring; and international trade.

Taxation: domestic taxation; international taxation; and indirect taxation: sales tax, VAT, service tax, customs duties, entry tax, excise duties and stamp duties.

Intellectual property: copyright and patent registration; protection and enforcement; registration of IP; and IP litigation.

Compliance and regulatory compliances, antitrust: corporate investigations and due diligence; fraud-based investigations; enterprise-wide compliance checks; corporate governance and best practices; regulatory – Reserve Bank of India, Enforcement Directorate, Competition Commission and SEBI; competition; and forensic investigation.

LanguagesEnglish
Hindi
regional Indian languages

Other officesPrincipal office: New Delhi
Associated offices: Bangalore
Chennai
Cochin
Orissa

MemberUSIBC (US India Business Council)
International Chamber of Commerce, India

Number of lawyers 65

Above material supplied by DMD Advocates.

Legal Developments in India

Legal Developments and updates from the leading lawyers in each jurisdiction. To contribute, send an email request to
  • BRAND-JACKING

    WHAT IS BRANDJACKING?
  • Post Marketing Surveillance of Drugs

    Post marketing surveillance is performed after market approval/clinical trials of drugs in India. The regulatory framework for conducting clinical trials of drugs is provided under the Drugs and Cosmetics Act, 1940 (“ Act ”) and the Drugs and Cosmetics Rules, 1945 (“ Rules ”). Further, Part X-A and Schedule Y of the Rules specifically deal with the statutory provisions applicable for clinical trial of drugs in India. Schedule Y divides Clinical trial of drugs into 4 Phases, namely, Human Pharmacology (Phase-I), Therapeutic exploratory trials (Phase-II), Therapeutic confirmatory trials (Phase III) and Post Marketing Trials (Phase-IV).
  • Protection of Biotechnology under Indian Laws

    According to the eighth annual survey conducted by the Association of Biotechnology-Led Enterprises (ABLE) and Bio Spectrum, the Indian biotech industry grew threefold in just five years to report revenues of US$ 3 billion in 2009-10, a rise of 17 per cent over the previous year. Maintaining the momentum of the previous years, the Indian biotech industry grew 16.28 per cent in FY2014; the total industry size was US$ 5 billion at the end of the financial year and it reached US$ 7 billion in FY2015. Fast-paced growth is likely to continue; the industry is expected to increase in size to USD11.6 billion by 2017, driven by a range   of factors such as growing demand, intensive R & D activities and strong government initiatives ( http://www.ibef.org/industry/biotechnology-india.aspx )
  • Cabinet Approves India’s IPR Policy - “Creative India; Innovative India: रचनात्म??

    The Union Cabinet on 13 May 2016 approved the National Intellectual Property Right (IPR) policy roadmap ( http://dipp.gov.in/English/Schemes/Intellectual_Property_Rights/National_IPR_Policy_12.05.2016.pdf ) to foster creativity and innovation, promote entrepreneurship and enhance socio development, enhance access to healthcare, food security and environmental protection. The Policy recognizes the abundance of creative and innovative energies that flow in India, and the need to tap into and channelize these energies towards a better and brighter future for all.
  • Real Estate - India

    Real Estate - India
  • SEBI’s Jurisdiction | Analysis of the Supreme Court judgment in the Sahara case

    The Securities and Exchange Board of India (SEBI) is responsible for investor protection and development and regulation of the securities market in India. The scope of SEBI’s jurisdiction over the issue of securities by public companies is an important issue. This issue was recently considered by the Supreme Court in Sahara India Real Estate Corporation Ltd. and Ors. v. Securities and Exchange Board of India and Anr., MANU/SC/0702/2012; (2012) 8 SCALE 101. This article analyses this judgment and its implications.
  • Mainstreaming the Alternative: Issuance of NCDs

    Debt financing is a significant means for corporates to raise capital. Indian regulators have taken a number of steps to deepen the Indian debt market. Permission has been granted to foreign institutional investors (FIIs) and qualified foreign investors (QFIs) to invest in non-convertible debentures (NCDs) issued by Indian companies. This article summarises the legal and regulatory requirements for Indian companies to issue NCDs to FIIs and QFIs.
  • Options – Not a Part of History Yet

    At the time when India is completing two decades of the economic liberalization there are several laurels which the policymakers can boast of.   The path-breaking shift from the license-raj to a regime focusing on regulation introduced by the Government of India in the landmark year 1991 have been continued through further economic reforms and the same has also found support from the regulators and the market players.
  • Liberalization Back on Track with the Relaxation of Share Transfer Norms

    Soon after the rollback of the much criticized aspect of the Consolidated Foreign Direct Investment policy dated October 1, 2011 which treated foreign investments in Indian securities as external commercial borrowings in case such investments conferred options on the foreign investors, the policy makers have brought more good news for the investor community.
  • Franchising in India

    In the last two decades, India has witnessed a sea change in its foreign investment policy resulting in it being one of the most preferred investment destinations. With growing globalisation and liberalisation, brand awareness has been created in the Indian masses and today India is the one of the biggest and fastest emerging markets for various businesses across the world. Being geographically vast and culturally diverse, India offers the most favorable franchising environment with a huge consumer market. Franchising in this respect has managed to pick up as a successful business module for local companies in India.